Patients taking the weight-loss drug semaglutide were less likely to die from COVID-19, according to a recent study. The patients who contracted COVID-19 while using a weekly 2.4 mg dose of ...

We are living in an epidemic of chronic disease, with a growing number of pesticides, chemicals and food additives implicated in the declining health of Americans. Since 2019, another factor has been ...

It wasn’t that long ago that people considered Moderna and Pfizer to be saviors. Their work during the COVID-19 pandemic brought on an unusual outpouring of support and goodwill toward the ...

A common drug may be able to cure a common illness. Around 1 in 4 people have developed long-haul symptoms of COVID-19, experiencing fatigue, brain fog, chronic cough, chest pain and more for three ...

Moore Vogel is a long Covid patient-researcher at Scripps Research and the Patient Led Research Collaborative (PLRC). Charlie McCone is a long Covid patient advocate, is a member of the PLRC, and has ...

Researchers continue looking at existing medicine for help in the fight against the novel coronavirus, because those drugs already exist and could quickly make a big difference. The latest lead for ...

Treatment options for mild-to-moderate COVID-19 are becoming increasingly well established. A systematic review and network meta-analysis published in The BMJ evaluated 40 treatments across 187 ...

A new oral GLP-1 therapy and the first preventive option for COVID-19 are among the pipeline drugs that payers and plan sponsors should be watching this spring, according to a new report. The pipeline ...

Fluvoxamine and metformin have anti-inflammatory and immunomodulatory properties that have led researchers to test their ability to prevent and treat long COVID and its symptoms. In a randomized trial ...

An antiviral drug that attacks a SARS-CoV-2 virus protein protects mice against many of the most severe effects of the disease, including some that can linger on. Trials on humans are yet to begin, ...